TrialClinical drug investigation2016

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies.

Tracey Roberts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.